Please wait while the formulary information is being retrieved.
ABREVA (DOCOSANOL)
- Herpes labialis
10 % topical cream
- Dosage information is not available
- None
Contraindicated
- None
Severe
Moderate
- None
- None
Contraindicated
- Immunocompromised patient
Severe
Moderate
- None
ABREVA (DOCOSANOL)
- Herpes labialis
- None
- None
More Frequent
Severe
Less Severe
- None
- Erythema
- Pruritus of skin
- Skin rash
- Treatment site sequelae
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- None
Less Severe
- Acne vulgaris
- Dry skin
Contraindicated
None
Severe Precaution
None
Management or Monitoring Precaution
None
Contraindicated
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Precaution Exists
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
No Known Risk
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Contraindicated
None
Precaution Exists
None
No Known Risk
None
- None
| Herpes labialis | |
| B00.1 | Herpesviral vesicular dermatitis |
| 0-9 | A-Z |
|---|---|
| B00.1 | Herpesviral vesicular dermatitis |
Formulary Reference Tool